SVRA
NASDAQ
$5.49
Savara Inc (SVRA)
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $10.94 (+99.27%)
Market Cap
$1.19B
FCF 5Y CAGR
+24.06%
Free Cash Flow Yield
-8.98%
Beta (5Y)
1.21
Price Chart
Valuation
Market Cap$1.19B
Forward P/E0.41
P/S145272.62
P/B6.61
Profitability
Gross Profit (TTM)-$81M
EBITDA-$134M
EPS-$0.65
Financial Health
Debt-to-Equity17.1%
Free Cash Flow Yield-8.98%
Growth & Risk
EPS 5Y CAGR-2.12%
FCF 5Y CAGR+24.06%
Beta (5Y)1.21
Sharpe Ratio1.77